Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: To combat invading pathogens, cells develop an adaptive immune response by changing their own genetic information. In vertebrates, the generation of genetic variation (somatic hypermutation) is an essential process for diversification and affinity maturation of antibodies that function to detect and sequester various foreign biomolecules. The activation-induced cytidine deaminase (AID) carries out hypermutation by modifying deoxycytidine bases in the variable region of the immunoglobulin locus that produces antibody. AID-generated deoxyuridine in DNA is mutagenic as it can be miss-recognized as deoxythymine, resulting in C to T mutations. CRISPR (clustered regularly interspaced short palindromic repeats)/Cas (CRISPR-associated) is a prokaryotic adaptive immune system that records and degrades invasive foreign DNA or RNA. The CRISPR/Cas system cleaves and incorporates foreign DNA/RNA segments into the genomic region called the CRISPR array. The CRISPR array is transcribed to produce crispr-RNA that serves as guide RNA (gRNA) for recognition of the complementary foreign DNA/RNA in a ribonucleoprotein complex with Cas proteins, which degrade the target. The CRISPR/Cas system has been repurposed as a powerful genome editing tool, because it can be programmed to cleave specific DNA sequence by providing custom gRNAs. RATIONALE: Although the precise mechanism by which AID specifically mutates the immunoglobulin locus remains elusive, targeting of AID activity is facilitated by the formation of a single-stranded DNA region, such as a transcriptional RNA/DNA hybrid (R-loop). The CRISPR/Cas system can be engineered to be nuclease-inactive. The nuclease-inactive form is capable of unfolding the DNA double strand in a protospacer adjacent motif (PAM) sequence-dependent manner so that the gRNA binds to complementary target DNA strand and forms an R-loop. The nuclease-deficient CRISPR/Cas system may serve as a suitable DNA-targeting module for AID to catalyze site-specific mutagenesis. RESULTS: To determine whether AID activity can be specifically targeted by the CRISPR/Cas system, we combined dCas9 (a nuclease-deficient mutant of Cas9) from Streptococcus pyogenes and an AID ortholog, PmCDA1 from sea lamprey, to form a synthetic complex (Target-AID) by either engineering a fusion between the two proteins or attaching a SH3 (Src 3 homology) domain to the C terminus of dCas9 and a SHL (SH3 interaction ligand) to the C terminus of PmCDA1. Both of these complexes performed highly efficient site-directed mutagenesis. The mutational spectrum was analyzed in yeast and demonstrated that point mutations were dominantly induced at cytosines within the range of three to five bases surrounding the –18 position upstream of the PAM sequence on the noncomplementary strand to gRNA. The toxicity associated with the nuclease-based CRISPR/Cas9 system was greatly reduced in the Target-AID complexes. Combination of PmCDA1 with the nickase Cas9(D10A) mutant, which retains cleavage activity for noncomplementary single-stranded DNA, was more efficient in yeast but also induced deletions as well as point mutations in mammalian cells. Addition of the uracil DNA glycosylase inhibitor protein, which blocks the initial step of the uracil base excision repair pathway, suppressed collateral deletions and further improved targeting efficiency. Potential off-target effects were assessed by whole-genome sequencing of yeast as well as deep sequencing of mammalian cells for regions that contain mismatched target sequences. These results showed that off-target effects were comparable to those of conventional CRISPR/Cas systems, with a reduced risk of indel formation. CONCLUSION: By expanding the genome editing potential of the CRISPR/Cas9 system by deaminase-mediated hypermutation, Target-AID demonstrated a very narrow range of targeted nucleotide substitution without the use of template DNA. Nickase Cas9 and uracil DNA glycosylase inhibitor protein can be used to boost the targeting efficiency. The reduced cytotoxicity will be beneficial for use in cells that are sensitive to artificial nucleases. Use of other types of nucleotide-modifying enzymes and/or other CRISPR-related systems with different PAM requirements will expand our genome-editing repertoire and capacity. A crippled CRISPR/Cas targets AID.: In vertebrate adaptive immunity, cytosine deaminase (AID or PmCDA1) induces somatic hypermutation at single-stranded DNA regions formed during transcription. The bacterial CRISPR/Cas9 immunity system recognizes and cleaves invasive DNA in a gRNA-dependent manner. AID and nuclease-deficient CRISPR/Cas9 are engineered to form a hybrid complex (Target-AID) that performs programmable cytosine mutations in a range of a few bases surrounding the –18 position upstream of PAM sequence of the noncomplementary DNA strand.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The second study used CRISPR-Cas9-mediated genome editing to remove a mutation in exon 23 in the mdx mouse model of DMD, providing partial recovery of functional dystrophin protein in skeletal myofibers and cardiac muscle 25,26,49 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [26]
In the citing paper
“Alternatives to DNA cleavage-induced editing include using CRISPR-Cas9 for direct chemical sequence alteration (base editing) 25,26 , providing RNA templates for gene alteration (prime editing) 27,28 , and for transcriptional control (CRISPR interference, CRISPRi; CRISPR activation, CRISPRa) 29,30 (Fig. 3).”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [26]
In the citing paper
“An alternative approach is to use CRISPR-Cas9 coupled to DNA editing enzymes that catalyze targeted A-to-G or Cto-T genomic sequence changes without inducing a break in DNA, potentially reversing pathogenic single-nucleotide changes or disabling genes via the introduction of a stop codon 25,26 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [26]
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y., & Honjo, T. (2000) · Cell · doi:10.1016/s0092-8674(00)00078-7 · Cited by 3,474
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2508 · Cited by 2,429
Rationally engineered Cas9 nucleases with improved specificity
Slaymaker, I. M., Gao, L., Zetsche, B., Scott, D. A., Yan, W. X., & Zhang, F. (2016) · Science · doi:10.1126/science.aad5227 · Cited by 2,414
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268
Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems
DiCarlo, J. E., Norville, J. E., Mali, P., Rios, X., Aach, J., & Church, G. M. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt135 · Cited by 1,566
Synthetic protein scaffolds provide modular control over metabolic flux
Dueber, J. E., Wu, G. C., Malmirchegini, G. R., Moon, T. S., Petzold, C. J., Ullal, A. V., Prather, K. L. J., & Keasling, J. D. (2009) · Nature Biotechnology · doi:10.1038/nbt.1557 · Cited by 1,242
Cas9 as a versatile tool for engineering biology
Mali, P., Esvelt, K. M., & Church, G. M. (2013) · Nature Methods · doi:10.1038/nmeth.2649 · Cited by 1,197
Cited by
Items 801–900 of 1,001
Reprogramming Microbial CO2-Metabolizing Chassis With CRISPR-Cas Systems
Yu, H., Wang, S., & Xia, P. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.897204 · Cited by 14
Rong, L., Chen, D., Huang, X., & Sun, L. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.08.076 · Cited by 11
Defining and targeting patterns of T cell dysfunction in inborn errors of immunity
Campos, J. S., & Henrickson, S. E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.932715 · Cited by 12
The history of genome editing: advances from the interface of chemistry & biology
Matsumoto, D., & Nomura, W. (2023) · Chemical Communications · doi:10.1039/d3cc00559c · Cited by 16
Skrekas, C., Limeta, A., Siewers, V., & David, F. (2023) · ACS Synthetic Biology · doi:10.1021/acssynbio.2c00690 · Cited by 11
Base editing corrects the common Salla disease SLC17A5 c.115C>T variant
Harb, J. F., Christensen, C. L., Kan, S., Rha, A. K., Andrade-Heckman, P., Pollard, L., Steet, R., Huang, J. Y., & Wang, R. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.08.024 · Cited by 13
CRISPR base editor-based targeted random mutagenesis (BE-TRM) toolbox for directed evolution
Shelake, R. M., Pramanik, D., & Kim, J. (2024) · BMB Reports · doi:10.5483/bmbrep.2023-0086 · Cited by 12
Ranzau, B. L., & Komor, A. C. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00958 · Cited by 12
CRISPR/Cas-based devices for mammalian synthetic biology
Kim, T., & Lu, T. K. (2019) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.04.015 · Cited by 11
Recent Advance in Genome Editing-Based Gene Modification in Pigs
Sato, M., Miyoshi, K., Kawaguchi, H., Inada, E., Saitoh, I., & Tanimoto, A. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.88022 · Cited by 10
Yoshioka, I., & Kirimura, K. (2021) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2021.01.011 · Cited by 13
Miyamoto, T., Akutsu, S. N., Tauchi, H., Kudo, Y., Tashiro, S., Yamamoto, T., & Matsuura, S. (2018) · Journal of Radiation Research · doi:10.1093/jrr/rry007 · Cited by 11
Screening of CRISPR/Cas base editors to target the AMD high-risk Y402H complement factor H variant.
Tran, M. T. N., Khalid, M. K. N. M., Pébay, A., Cook, A. L., Liang, H. H., Wong, R. C. B., Craig, J. E., Liu, G., Hung, S. S. C., & Hewitt, A. W. (2019) · PubMed · Cited by 15
Gossing, M., Limeta, A., Skrekas, C., Wigglesworth, M. J., Davis, A., Siewers, V., & David, F. (2023) · ACS Synthetic Biology · doi:10.1021/acssynbio.2c00689 · Cited by 10
Deconstructing cancer with precision genome editing
Johnson, G. A., Gould, S. I., & Rivera, F. J. S. (2024) · Biochemical Society Transactions · doi:10.1042/bst20230984 · Cited by 11
Zhang, Y., Zheng, Y., Hu, Q., Hu, Z. Q., Sun, J., Cheng, P., Rao, X., & Jiang, X. (2024) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2024.04.016 · Cited by 11
Dorighi, K. M., Zhu, A., Fortin, J., Lo, J. H.-H., Sudhamsu, J., Wendorff, T. J., Durinck, S., Callow, M. G., Foster, S. A., & Haley, B. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114313 · Cited by 13
Efficient CRISPR‐mediated C‐to‐T base editing in Komagataella phaffii
Wu, L., Xu, Y., & Yu, X. (2024) · Biotechnology Journal · doi:10.1002/biot.202400115 · Cited by 11
Abe, N., & Numata, K. (2024) · Polymer Journal · doi:10.1038/s41428-024-00973-y · Cited by 13
Contiliani, D. F., Sretenovic, S., Dailey, M., Zhou, M., Cheng, Y., Creste, S., Xiao, S., & Qi, Y. (2025) · Plant Biotechnology Journal · doi:10.1111/pbi.70000 · Cited by 10
Charting the development and engineering of CRISPR base editors: lessons and inspirations
Zou, S., Sun, Y., & Tang, W. (2025) · Cell chemical biology · doi:10.1016/j.chembiol.2025.05.003 · Cited by 12
Evaluation and prediction of guide RNA activities in genome-editing tools
Kim, H. K., & Kim, S. (2025) · Nature Reviews Bioengineering · doi:10.1038/s44222-025-00352-z · Cited by 16
Treatment of a severe vascular disease using a bespoke CRISPR–Cas9 base editor in mice
Alves, C. R. R., Das, S., Krishnan, V., Ha, L. L., Fox, L. R., Stutzman, H. E., Shamber, C., Kalailingam, P., McCarthy, S., Cardenas, C. L. L., et al. (2025) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01499-1 · Cited by 20
Next-generation human genetics for organism-level systems biology
Ukai, H., Sumiyama, K., & Ueda, H. R. (2019) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2019.03.003 · Cited by 10
Zhou, Q., Zhang, Y., Xiao-xiang, L., Wang, C., Pei, X., Lu, Y., Cao, C., Xu, C., & Zhang, B. (2021) · Biotechnology Journal · doi:10.1002/biot.202000623 · Cited by 10
Powerful Microbial Base-Editing Toolbox: From Optimization Strategies to Versatile Applications
Li, K., Qin, L.-Y., Zhang, Z., Yan, C.-X., Gu, Y. M., Sun, X., & Huang, H. (2023) · ACS Synthetic Biology · doi:10.1021/acssynbio.3c00141 · Cited by 10
Targeted Base Editing with CRISPR-Deaminase in Tomato
Shimatani, Z., Ariizumi, T., Fujikura, U., Kondo, A., Ezura, H., & Nishida, K. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-8991-1_22 · Cited by 10
Self-citationKang, B., Woo, J. W., Kim, S., Bae, S., Choi, M., Kim, J., & Kim, S. (2019) · Plant Biotechnology Reports · doi:10.1007/s11816-019-00572-x · Cited by 10
Li, B., Li, Y.-Q., Zhao, D., Yang, J., Ma, Y., Bi, C., & Zhang, X. (2021) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2021.11.007 · Cited by 15
A CRISPR reimagining: New twists and turns of CRISPR beyond the genome‐engineering revolution
Plummer, R. J., Guo, Y., & Peng, Y. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26406 · Cited by 11
Recent advances of genome editing and related technologies in China
Sun, W. C., & Wang, H. (2020) · Gene Therapy · doi:10.1038/s41434-020-0181-5 · Cited by 10
Innovative Therapies for Hemoglobin Disorders
Sii-Felice, K., Nègre, O., Brendel, C., Tubsuwan, A., Morel-à-l’Huissier, E., Filardo, C., & Payen, E. (2020) · BioDrugs · doi:10.1007/s40259-020-00439-6 · Cited by 10
High-precision CRISPR-Cas9 base editors with minimized bystander and off-target mutationsPreprint
Gehrke, J. M., Cervantes, O., Clement, K., Pinello, L., & Joung, J. K. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/273938 · Cited by 10
Głów, D., Meyer, S., Roldán, I. G., Akingunsade, L., Riecken, K., & Fehse, B. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.07.004 · Cited by 11
CRISPR‐Cas Biochemistry and CRISPR‐Based Molecular Diagnostics
Weng, Z., You, Z., Yang, J., Mohammad, N., Lin, M., Wei, Q., Gao, X., & Zhang, Y. (2023) · Angewandte Chemie · doi:10.1002/ange.202214987 · Cited by 12
Expanding the flexibility of base editing for high-throughput genetic screens in bacteria
Gawlitt, S., Collins, S. P., Yu, Y., Blackman, S. A., Barquist, L., & Beisel, C. L. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae174 · Cited by 9
Precise genome editing process and its applications in plants driven by AI
Jiang, B., An, Z., Niu, L., & Qin, D. (2025) · Functional & Integrative Genomics · doi:10.1007/s10142-025-01619-9 · Cited by 10
Gene therapy for epilepsy: An emerging, promising approach for a serious neurological disorder
Ledri, M., & Kokaia, M. (2025) · Journal of Internal Medicine · doi:10.1111/joim.70059 · Cited by 15
Bindal, G., & Rath, D. (2025) · Synthetic biology and engineering · doi:10.70322/sbe.2025.10014 · Cited by 15
Plant base editing: a decade of progress and future applications
Zhang, R., Zheng, Z., Li, G., Zheng, X., Su, L., Yuan, X., Li, T., Tan, J., Zeng, D., Zhang, S., et al. (2025) · aBIOTECH · doi:10.1016/j.abiote.2025.100003 · Cited by 12
Establishment of MDR1-knockout human induced pluripotent stem cell line
Negoro, R., Kawai, K., Ichikawa, M., Deguchi, S., Takayama, K., & Mizuguchi, H. (2020) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2020.01.009 · Cited by 9
Genome Editing and Designer Crops for the Future
Rana, S., Aggarwal, P., Shukla, V., Giri, U., Verma, S., & Muthamilarasan, M. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1875-2_3 · Cited by 11
Hunziker, J., Nishida, K., Kondo, A., Ariizumi, T., & Ezura, H. (2022) · Frontiers in Plant Science · doi:10.3389/fpls.2022.848560 · Cited by 10
Self-citationEfficient PAM-Less Base Editing for Zebrafish Modeling of Human Genetic Disease with zSpRY-ABE8e
Zheng, S., Liang, F., Zhang, Y., Fei, J., Qin, W., & Liu, Y. (2023) · Journal of Visualized Experiments · doi:10.3791/64977 · Cited by 10
Cytosine base editors optimized for genome editing in potato protoplasts
Westberg, I. N., Carlsen, F. M., Johansen, I. E., & Petersen, B. L. (2023) · Frontiers in Genome Editing · doi:10.3389/fgeed.2023.1247702 · Cited by 12
Nandy, K., Babu, D., Rani, S., Joshi, G., Ijee, S., George, A., Palani, D., Premkumar, C., Rajesh, P., Vijayanand, S., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-42174-2 · Cited by 11
Genetic Engineering: A Powerful Tool for Crop Improvement
Bhattacharjee, M., Meshram, S., Dayma, J., Pandey, N., Abdallah, N. A., Hamwieh, A., Fouad, N., & Acharjee, S. (2024) · Sustainability Sciences in Asia and Africa · doi:10.1007/978-981-99-4673-0_10 · Cited by 16
CRISPR/Cas9 applications in gene therapy for primary immunodeficiency diseases
Ravin, S. S. D., & Brault, J. (2019) · Emerging Topics in Life Sciences · doi:10.1042/etls20180157 · Cited by 10
The milestone of genetic screening: Mammalian haploid cells
Sun, S., Zhao, Y., & Shuai, L. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.09.006 · Cited by 10
Song, B., Kang, C. Y., Han, J. H., Kano, M., Konnerth, A., & Bae, S. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.04.051 · Cited by 8
Ghorbani, A., Quinlan, E. M., & Larijani, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.642343 · Cited by 10
Choi, D. E., Shin, J. W., Zeng, S., Hong, E. P., Jang, J.-H., Loupe, J. M., Wheeler, V. C., Stutzman, H. E., Kleinstiver, B., & Lee, J. (2023) · eLife · doi:10.7554/elife.89782 · Cited by 36
Disruptive non-disruptive applications of CRISPR/Cas9
Schmid-Burgk, J. L. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.06.001 · Cited by 11
Budzko, L., Jackowiak, P., Kamel, K., Sarzyńska, J., Bujnicki, J. M., & Figlerowicz, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-03936-x · Cited by 10
Mammalian synthetic biology by CRISPRs engineering and applications
Katayama, K., Mitsunobu, H., & Nishida, K. (2019) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.05.020 · Cited by 9
Self-citationForward genetic approach for behavioral neuroscience using animal models
Funato, H. (2020) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.96.002 · Cited by 10
Beyond CRISPR: A guide to the many other ways to edit a genome
Ledford, H. K. (2016) · Nature · doi:10.1038/536136b · Cited by 11
Precise and programmable C:G to G:C base editing in genomic DNAPreprint
Chen, L., Park, J. E., Paa, P., Rajakumar, P. D., Chew, Y. T., Manivannan, S. N., & Chew, W. L. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.21.213827 · Cited by 9
Li, G., Dong, X., Luo, J., Yuan, T., Li, T., Zhao, G., Zhang, H., Zhou, J., Zeng, Z., Cui, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52485-1 · Cited by 9
Srivastava, R. A. K. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.08.010 · Cited by 8
Zhou, X., Gao, J., Luo, L., Huang, C., Wu, J., & Wang, X. (2024) · Communications Biology · doi:10.1038/s42003-024-07078-5 · Cited by 12
Lee, J. M., Zeng, J., Liu, P., Nguyen, M. A., Loustaunau, D. S., Bauer, D. E., Yılmaz, N. K., Wolfe, S. A., & Schiffer, C. A. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae1217 · Cited by 10
Genome modification in plant mitochondria
Forner, J. (2025) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiaf197 · Cited by 8
Recent Advances in Genome Base Editing Technology and Its Applications in Industrial Microorganism
Zheng, Y., Du, F., Hang, Y., Ma, W., Yang, G., Wu, N., & Sun, X. (2025) · Biotechnology Journal · doi:10.1002/biot.70052 · Cited by 9
Xing, D., Bai, T., Neyisci, O., Paylakhi, S. Z., Duval, A. J., Tekin, Y., & Adli, M. (2025) · Nature Communications · doi:10.1038/s41467-025-61848-1 · Cited by 10
High-efficiency base editing for nuclear and mitochondrial DNA with an optimized DYW-like deaminase
Kweon, J., Park, S., Jeon, M. Y., Lim, K., Jang, G., Jang, A.-H., Lee, M., Seok, C., Lee, C., Park, S., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.08.007 · Cited by 10
Zheng, L., Zhao, W., Li, S., Luo, X., Wei, Y., Zhang, Y., Ye, Z., Li, S., Wang, M., Tan, J., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf717 · Cited by 9
Chakravorty, M., Nanda, M., Arora, N., Singh, S., Kumar, V., & Deshwal, S. (2022) · Plant Gene · doi:10.1016/j.plgene.2022.100369 · Cited by 9
The Promises and Pitfalls of CRISPR-Mediated Base Editing in Stem Cells
Wong, P. K., Zamberi, N. N. M., Syafruddin, S. E., Cheah, F., Azmi, N., Law, J. X., & Chua, E. W. (2023) · The CRISPR Journal · doi:10.1089/crispr.2023.0013 · Cited by 9
Wichmann, M., Maire, C. L., Nuppenau, N., Habiballa, M., Uhde, A., Kolbe, K., Schröder, T., Lamszus, K., Fehse, B., & Głów, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411399 · Cited by 10
Adenine base editor corrected ADPKD point mutations in hiPSCs and kidney organoids
Wang, J., Qiu, Y., Zhang, L., Zhou, X., Hu, S., Liu, Q., Yin, S., Su, Z., Liu, S., Liu, H., et al. (2024) · Advanced Biotechnology · doi:10.1007/s44307-024-00026-8 · Cited by 9
Chen, J., Su, S., Pickar‐Oliver, A., Chiarella, A. M., Hahn, Q., Goldfarb, D., Cloer, E. W., Small, G. W., Sivashankar, S., Ramsden, D. A., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae761 · Cited by 9
One-for-all gene inactivation via PAM-independent base editing in bacteria
Li, X., Wei, Y., Wang, S., Wang, S., & Xia, P. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.108113 · Cited by 10
A comprehensive all-in-one CRISPR toolbox for large-scale screens in plants
Cheng, Y., Li, G., Qi, A., Mandlik, R., Pan, C., Wang, D., Ge, S., & Qi, Y. (2025) · The Plant Cell · doi:10.1093/plcell/koaf081 · Cited by 10
Endo, M., Nishizawa‐Yokoi, A., & Toki, S. (2018) · Springer eBooks · doi:10.1007/978-981-10-7461-5_27 · Cited by 8
Frontiers of CRISPR-Cas9 for Cancer Research and Therapy
Banerjee, A., Malonia, S. K., & Dutta, S. (2021) · Journal of Exploratory Research in Pharmacology · doi:10.14218/jerp.2020.00033 · Cited by 11
Chemical and Biological Approaches to Interrogate off-Target Effects of Genome Editing Tools
Lei, Z., Meng, H., Zhuang, Y., Zhu, Q., & Yi, C. (2023) · ACS Chemical Biology · doi:10.1021/acschembio.2c00836 · Cited by 10
Accelerating crop domestication through genome editing for sustainable agriculture
Pattnaik, D., Avinash, S. P., Panda, S., Bansal, K. C., Chakraborti, M., Kar, M. K., Baig, M. J., & Molla, K. A. (2023) · Journal of Plant Biochemistry and Biotechnology · doi:10.1007/s13562-023-00837-1 · Cited by 12
Chirco, K. R., Martinez, C., & Lamba, D. A. (2023) · Vision Research · doi:10.1016/j.visres.2023.108257 · Cited by 9
Genome Editing: Advances and Prospects
Patel, J., & Mishra, A. (2019) · Springer eBooks · doi:10.1007/978-981-13-8499-8_7 · Cited by 10
Ohtsuki, N., Kizawa, K., Mori, A., Nishizawa‐Yokoi, A., Komatsuda, T., Yoshida, H., Hayakawa, K., Toki, S., & Saika, H. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2020.617713 · Cited by 9
Immunotherapy to get on point with base editing
Harbottle, J. A. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.04.003 · Cited by 8
Germline Editing of Drosophila Using CRISPR-Cas9-Based Cytosine and Adenine Base Editors
Thakkar, N., Hejzlarova, A., Brabec, V., & Doležel, D. (2023) · The CRISPR Journal · doi:10.1089/crispr.2023.0026 · Cited by 7
Applications of CRISPR technologies to the development of gene and cell therapy
Park, C.-S., Habib, O., Lee, Y.-S., & Hur, J. K. (2024) · BMB Reports · doi:10.5483/bmbrep.2023-0221 · Cited by 13
Yu, Y., Yuan, Q., Liu, Z., Tong, B., & Shi, S. (2025) · ACS Synthetic Biology · doi:10.1021/acssynbio.5c00359 · Cited by 8
Zhang, H., Li, Y., Li, J., Li, X., & Li, T. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17111405 · Cited by 9
Strategies and mechanisms of precision genome engineering: From gene editing to genome writing
Huang, K., Tian, J., Zhao, W., Zhang, S., Xiang, L., Yang, M., Ls, L., Huang, Y., Zhang, N., Sun, L., et al. (2026) · iMetaOmics. · doi:10.1002/imo2.70115 · Cited by 9
A brief review of genome editing technology for generating animal models
Wang, H., Wu, S., Capecchi, M. R., & Jaenisch, R. (2020) · Frontiers of Agricultural Science and Engineering · doi:10.15302/j-fase-2019309 · Cited by 8
Saccharomyces cerevisiae as a Heterologous Host for Natural Products
Otto, M., Liu, D., & Siewers, V. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2273-5_18 · Cited by 9
Genetically engineered pig models of neurological diseases
Li, C., Li, J., Lai, L., Li, S., & Yan, S. (2022) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2022.13 · Cited by 9
Base Editing in Poplar Through an Agrobacterium-Mediated Transformation Method
Li, G., Sretenovic, S., Coleman, G. D., & Qi, Y. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3131-7_4 · Cited by 9
Seys, F. M., Humphreys, C. M., Tomi-Andrino, C., Li, Q., Millat, T., Yang, S., & Minton, N. P. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1211197 · Cited by 5
Chen, Z., Kwan, S., Mir, A., Hazeltine, M. D., Shin, M., Liang, S., Chan, I. L., Kelly, K. L., Ghanta, K. S., Gaston, N., et al. (2023) · The CRISPR Journal · doi:10.1089/crispr.2023.0048 · Cited by 7
Taming AID mutator activity in somatic hypermutation
Qin, Y., & Meng, F. (2024) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2024.03.011 · Cited by 8
Fan, X., Gao, Z.-F., Ling, D.-D., Wang, D., Cui, Y. J., Du, H.-Q., Li, C., & Zhou, X. (2024) · Military Medical Research · doi:10.1186/s40779-024-00530-x · Cited by 7
Applied models and molecular characteristics of small cell lung cancer
Fűr, G. M., Nemes, K., Magó, É., Benő, A., Topolcsányi, P., Moldvay, J., & Pongor, L. S. (2024) · Pathology & Oncology Research · doi:10.3389/pore.2024.1611743 · Cited by 9
Efficient Rescue of Retinal Degeneration in Pde6a Mice by Engineered Base Editing and Prime Editing
Liu, Z., Chen, S., Davis, A. E., Lo, C., Wang, Q. K., Li, T., Ning, K., Zhāng, Q., Zhao, J., Wang, S., et al. (2024) · Advanced Science · doi:10.1002/advs.202405628 · Cited by 14
CRISPR-Cas systems for genome editing of mammalian cells
Mani, I., Arazoe, T., & Singh, V. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.01.011 · Cited by 11
Self-citationFan, J. J., Ding, Y., Ren, C., Song, Z., Yuan, J., Chen, Q., Du, C., Li, C., Wang, X., & Shu, W. (2021) · Communications Biology · doi:10.1038/s42003-021-02406-5 · Cited by 8
dCas9 binding inhibits the initiation of base excision repair in vitro
Antony, J. S., Roberts, S. A., Wyrick, J. J., & Hinz, J. M. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103257 · Cited by 7
Metadata
- Authors
- Nishida, K., Arazoe, T., Yachie, N., Banno, S., Kakimoto, M., Tabata, M., Mochizuki, M., Miyabe, A., Araki, M., Hara, K. Y., Shimatani, Z., & Kondo, A.
- Affiliations
- Kobe University (JP)
- Keio University (JP)
- Shizuoka University (JP)
- Corresponding author
- Kondo, Akihiko
- ORCID
- Venue
- Science
- Published
- 2016-09-16
- Volume
- 353
- Issue
- 6305
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2480829753
- Cited by
- 1,349
- References
- 27
- Citations by year
- 2026: 69 · 2025: 124 · 2024: 151 · 2023: 152 · 2022: 181 · 2021: 157 · 2020: 167 · 2019: 137 · 2018: 112 · 2017: 88 · 2016: 10
- FWCI
- 60.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports and Technology (MEXT) of Japan
- Ministry of Economy, Trade and Industry (METI), Japan
- JSPS KAKENHI (26119710, 16K14654)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- activation-induced cytidine deaminase, CRISPR/Cas9, dCas9, sea lamprey, somatic hypermutation, R-loops, site-directed mutagenesis, genome editing, immunoglobulin variable region, affinity maturation
- MeSH terms
- Gene Editing, CRISPR-Associated Protein 9, AICDA (Activation-Induced Cytidine Deaminase), Alleles, Animals, Bacteria, Bacterial Proteins, Cricetulus, Cytidine, Cytidine Deaminase, Deoxyribonuclease I, DNA, Endonucleases, Enzyme Inhibitors, Immune System, RNA, Saccharomyces cerevisiae, Vertebrates, CHO Cells, Point Mutation, Gene Targeting, Uracil-DNA Glycosidase, INDEL Mutation, Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.